- CA$21.53m
- CA$25.77m
Annual income statement for ReGen III, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 3.12 | 3.84 | 12.6 | 5.7 | 3.91 |
| Operating Profit | -3.12 | -3.84 | -12.6 | -5.7 | -3.91 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -4.74 | -4.73 | -12.5 | -5.81 | -3.79 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -4.74 | -4.73 | -12.5 | -5.65 | -3.74 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -4.74 | -4.73 | -12.5 | -5.65 | -3.74 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -4.74 | -4.73 | -12.5 | -5.65 | -3.74 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.052 | -0.102 | -0.11 | -0.047 | -0.031 |